Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $77.0600 (-1.7%) ($76.5700 - $78.5100) on Wed. Sep. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.43% (three month average) | RSI | 58 | Latest Price | $77.0600(-1.7%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 1.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) XLC(35%) IBB(31%) VFMO(29%) XLV(29%) BOTZ(27%) | Factors Impacting SGEN price | SGEN will decline at least -0.715% in a week (0% probabilities). VIXM(-9%) UUP(-7%) VXX(-6%) DIA(-5%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.715% (StdDev 1.43%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $77.43(-0.48%) | 10 Day Moving Average | $77.14(-0.1%) | 20 Day Moving Average | $76.06(1.31%) | To recent high | -1.7% | To recent low | 18.9% | Market Cap | $13.398b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |